PKC ζ-mTOR pathway : a new target for rituximab therapy in follicular lymphoma. Commentary

Saved in:
Bibliographic Details
Published in:Blood 2008, Vol.111 (1)
Main Authors: BONAVIDA, Benjamin, LESEUX, Ludivine, LAURENT, Guy, LAURENT, Camille, RIGO, Maxime, BLANC, Amandine, OLIVE, Daniel, BEZOMBES, Christine
Format: Article
Language:English
Subjects:
Antineoplastic agents
Biological and medical sciences
Hematologic and hematopoietic diseases
Immunotherapy
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Medical sciences
Pharmacology. Drug treatments
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 1
container_start_page
container_title Blood
container_volume 111
creator BONAVIDA, Benjamin
LESEUX, Ludivine
LAURENT, Guy
LAURENT, Camille
RIGO, Maxime
BLANC, Amandine
OLIVE, Daniel
BEZOMBES, Christine
description
format article
fullrecord <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_19953489</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19953489</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_199534893</originalsourceid><addsrcrecordid>eNqNjEsKwjAURYMoWD97eBOHlfSn1mlRBAeKdOZAniW1kaQNSUrNxlyGa7IDF-DoDs45d0C8IAk3PqUhHRKPUrry43QdjMnEmCelQRyFiUeu52MGn7cv89MFFNqqQwdbQKhZBxb1g1koGw2a2_bFJd7BVkyjcsDrHgjBi1agBuGkqhqJS8gaKVndp25GRiUKw-a_nZLFfpdnB1-hKVCUGuuCm5vS_a92tyBNkyjepNG_3heCXkZW</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>PKC ζ-mTOR pathway : a new target for rituximab therapy in follicular lymphoma. Commentary</title><source>ScienceDirect Journals</source><creator>BONAVIDA, Benjamin ; LESEUX, Ludivine ; LAURENT, Guy ; LAURENT, Camille ; RIGO, Maxime ; BLANC, Amandine ; OLIVE, Daniel ; BEZOMBES, Christine</creator><creatorcontrib>BONAVIDA, Benjamin ; LESEUX, Ludivine ; LAURENT, Guy ; LAURENT, Camille ; RIGO, Maxime ; BLANC, Amandine ; OLIVE, Daniel ; BEZOMBES, Christine</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><language>eng</language><publisher>Washington, DC: The Americain Society of Hematology</publisher><subject>Antineoplastic agents ; Biological and medical sciences ; Hematologic and hematopoietic diseases ; Immunotherapy ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Medical sciences ; Pharmacology. Drug treatments</subject><ispartof>Blood, 2008, Vol.111 (1)</ispartof><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19953489$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>BONAVIDA, Benjamin</creatorcontrib><creatorcontrib>LESEUX, Ludivine</creatorcontrib><creatorcontrib>LAURENT, Guy</creatorcontrib><creatorcontrib>LAURENT, Camille</creatorcontrib><creatorcontrib>RIGO, Maxime</creatorcontrib><creatorcontrib>BLANC, Amandine</creatorcontrib><creatorcontrib>OLIVE, Daniel</creatorcontrib><creatorcontrib>BEZOMBES, Christine</creatorcontrib><title>PKC ζ-mTOR pathway : a new target for rituximab therapy in follicular lymphoma. Commentary</title><title>Blood</title><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Immunotherapy</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqNjEsKwjAURYMoWD97eBOHlfSn1mlRBAeKdOZAniW1kaQNSUrNxlyGa7IDF-DoDs45d0C8IAk3PqUhHRKPUrry43QdjMnEmCelQRyFiUeu52MGn7cv89MFFNqqQwdbQKhZBxb1g1koGw2a2_bFJd7BVkyjcsDrHgjBi1agBuGkqhqJS8gaKVndp25GRiUKw-a_nZLFfpdnB1-hKVCUGuuCm5vS_a92tyBNkyjepNG_3heCXkZW</recordid><startdate>2008</startdate><enddate>2008</enddate><creator>BONAVIDA, Benjamin</creator><creator>LESEUX, Ludivine</creator><creator>LAURENT, Guy</creator><creator>LAURENT, Camille</creator><creator>RIGO, Maxime</creator><creator>BLANC, Amandine</creator><creator>OLIVE, Daniel</creator><creator>BEZOMBES, Christine</creator><general>The Americain Society of Hematology</general><scope>IQODW</scope></search><sort><creationdate>2008</creationdate><title>PKC ζ-mTOR pathway : a new target for rituximab therapy in follicular lymphoma. Commentary</title><author>BONAVIDA, Benjamin ; LESEUX, Ludivine ; LAURENT, Guy ; LAURENT, Camille ; RIGO, Maxime ; BLANC, Amandine ; OLIVE, Daniel ; BEZOMBES, Christine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_199534893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Immunotherapy</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BONAVIDA, Benjamin</creatorcontrib><creatorcontrib>LESEUX, Ludivine</creatorcontrib><creatorcontrib>LAURENT, Guy</creatorcontrib><creatorcontrib>LAURENT, Camille</creatorcontrib><creatorcontrib>RIGO, Maxime</creatorcontrib><creatorcontrib>BLANC, Amandine</creatorcontrib><creatorcontrib>OLIVE, Daniel</creatorcontrib><creatorcontrib>BEZOMBES, Christine</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BONAVIDA, Benjamin</au><au>LESEUX, Ludivine</au><au>LAURENT, Guy</au><au>LAURENT, Camille</au><au>RIGO, Maxime</au><au>BLANC, Amandine</au><au>OLIVE, Daniel</au><au>BEZOMBES, Christine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PKC ζ-mTOR pathway : a new target for rituximab therapy in follicular lymphoma. Commentary</atitle><jtitle>Blood</jtitle><date>2008</date><risdate>2008</risdate><volume>111</volume><issue>1</issue><issn>0006-4971</issn><eissn>1528-0020</eissn><cop>Washington, DC</cop><pub>The Americain Society of Hematology</pub></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2008, Vol.111 (1)
issn 0006-4971
1528-0020
language eng
recordid cdi_pascalfrancis_primary_19953489
source ScienceDirect Journals
subjects Antineoplastic agents
Biological and medical sciences
Hematologic and hematopoietic diseases
Immunotherapy
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Medical sciences
Pharmacology. Drug treatments
title PKC ζ-mTOR pathway : a new target for rituximab therapy in follicular lymphoma. Commentary
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T07%3A28%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PKC%20%CE%B6-mTOR%20pathway%20:%20a%20new%20target%20for%20rituximab%20therapy%20in%20follicular%20lymphoma.%20Commentary&rft.jtitle=Blood&rft.au=BONAVIDA,%20Benjamin&rft.date=2008&rft.volume=111&rft.issue=1&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E19953489%3C/pascalfrancis%3E%3Cgrp_id%3Ecdi_FETCH-pascalfrancis_primary_199534893%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true